$2500 | Single User
$5000 | Site License
$7500 | Global License

Rheumatic Disorders Global Clinical Trials Review, H2, 2018
[Report Updated: 31-07-2018]

Published by Global Data: 31 Jul 2018 | 223163 | In Stock
Related Topics: Clinical Trials

Introduction

Rheumatic Disorders Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, “Rheumatic Disorders Global Clinical Trials Review, H2, 2018" provides an overview of Rheumatic Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Rheumatic Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Rheumatic Disorders Global Clinical Trials Review, H2, 2018 [Report Updated: 31-07-2018]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    GlobalData Clinical Trials Report Coverage 6

    Clinical Trials by Region 7

    Clinical Trials and Average Enrollment by Country 8

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

    Top Five Countries Contributing to Clinical Trials in Europe 12

    Top Countries Contributing to Clinical Trials in North America 13

    Top Countries Contributing to Clinical Trials in Middle East and Africa 14

    Top Countries Contributing to Clinical Trials in Central and South America 15

    Clinical Trials by G7 Countries: Proportion of Rheumatic Disorders to Musculoskeletal Disorders Clinical Trials 16

    Clinical Trials by Phase in G7 Countries 18

    Clinical Trials in G7 Countries by Trial Status 19

    Clinical Trials by E7 Countries: Proportion of Rheumatic Disorders to Musculoskeletal Disorders Clinical Trials 20

    Clinical Trials by Phase in E7 Countries 22

    Clinical Trials in E7 Countries by Trial Status 23

    Clinical Trials by Phase 24

    In Progress Trials by Phase 25

    Clinical Trials by Trial Status 26

    Clinical Trials by End Point Status 27

    Subjects Recruited Over a Period of Time 28

    Clinical Trials by Sponsor Type 29

    Prominent Sponsors 30

    Top Companies Participating in Rheumatic Disorders Therapeutics Clinical Trials 32

    Prominent Drugs 33

    Clinical Trial Profile Snapshots 34

    Appendix 98

    Abbreviations 98

    Definitions 98

    Research Methodology 99

    Secondary Research 99

    About GlobalData 100

    Contact Us 100

    Disclaimer 100

    Source 100

List Of Tables
in Rheumatic Disorders Global Clinical Trials Review, H2, 2018 [Report Updated: 31-07-2018]

List of Tables

Rheumatic Disorders Therapeutics, Global, Clinical Trials by Region, 2018* 7

Rheumatic Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Rheumatic Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Rheumatic Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11

Rheumatic Disorders Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12

Rheumatic Disorders Therapeutics Clinical Trials, North America, Top Countries, 2018* 13

Rheumatic Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14

Rheumatic Disorders Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15

Proportion of Rheumatic Disorders to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2018* 17

Rheumatic Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18

Rheumatic Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19

Proportion of Rheumatic Disorders to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2018* 21

Rheumatic Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22

Rheumatic Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23

Rheumatic Disorders Therapeutics, Global, Clinical Trials by Phase, 2018* 24

Rheumatic Disorders Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 25

Rheumatic Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26

Rheumatic Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27

Rheumatic Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28

Rheumatic Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 29

Rheumatic Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31

Rheumatic Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32

Rheumatic Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33

List Of Figures, Charts and Diagrams
in Rheumatic Disorders Global Clinical Trials Review, H2, 2018 [Report Updated: 31-07-2018]

List of Figures

Rheumatic Disorders Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Rheumatic Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Rheumatic Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Rheumatic Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11

Rheumatic Disorders Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12

Rheumatic Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13

Rheumatic Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14

Rheumatic Disorders Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 15

Proportion of Rheumatic Disorders to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2018* 16

Rheumatic Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18

Rheumatic Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19

Proportion of Rheumatic Disorders to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2018* 20

Rheumatic Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22

Rheumatic Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23

Rheumatic Disorders Therapeutics, Global, Clinical Trials by Phase (%), 2018* 24

Rheumatic Disorders Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 25

Rheumatic Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26

Rheumatic Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27

Rheumatic Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28

Rheumatic Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 29

Rheumatic Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30

Rheumatic Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32

Rheumatic Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33

GlobalData Methodology 99

Additional Details

Publisher

Global Data

Publisher Information

Reference

223163 | GDHC5115CTIDB

Number of Pages

100

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Rheumatology Therapeutics Market Size study, by Disease Type (Rheumatoid Arthritis, Ankylosing Spondylitis, Osteoarthritis, Lupus, Gout, Others), by Drug Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Disease Modifying Anti-Rheumatic Drugs (DMARDs), Corticosteroids, Others), by Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospitals, Others) and Regional Forecas
Global Rheumatology Therapeutics Market valued approximately USD 44.38 billion in 2018 is anticipate...
25 Jun 2019 by Bizwit Research and Consulting USD $3,950 More Info
2019 Rheumatic Disorders Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Rheumatic Disorders Clinical Trials Study” provides complete...
24 Apr 2019 by VPA Research USD $1,799 More Info
Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry
Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibito...
01 Jan 2019 by GBI Research USD $4,995 More Info
Acute Rheumatic Carditis-API Insights, 2017
The active pharmaceutical ingredients worldwide market is in continuous development from the recent ...
30 May 2017 by Delve Insight USD $1,250 More Info
Acute Rheumatic Carditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Acute Rheumatic Carditis-Global API Manufacturers, Marketed and Phase III Dr...
30 May 2017 by Delve Insight USD $2,000 More Info
Rheumatic Disorders Global Clinical Trials Review, H2, 2015
Rheumatic Disorders Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report...
30 Oct 2015 by Global Data USD $2,500 More Info

This report is published by Global Data

Download Free Report Summary PDF

Rheumatic Disorders Global Clinical Trials Review, H2, 2018 [Report Updated: 31-07-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...